Results 11 to 20 of about 288,544 (208)

NEW WAYS OF TREATING PERENNIAL ALLERGIC RHINITIS [PDF]

open access: yesНаука и инновации в медицине, 2018
Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov Selecting the proper treatment of perennial allergic rhinitis (PAR) today is often unsuccessful.
N P Dzhimsheleishvili   +2 more
doaj   +2 more sources

Evaluation of allergic etiology in perennial rhinitis.

open access: yesAnnals of allergy, 1985
In 197 patients with perennial rhinitis, 49 patients (24.9%) were found to be allergic to perennial inhalant allergens, 37 patients (18.8%) allergic to seasonal allergens, 52 patients (26.4%) had food intolerance, 12 patients (6.6%) showed evidence of nasal infection, and in 46 patients (23.3%) etiology was undetermined.
E.A. Pastorello   +7 more
core   +5 more sources

The efficacy and safety of ciclesonide for the treatment of perennial allergic rhinitis: a systematic review and meta-analysis

open access: yesBrazilian Journal of Otorhinolaryngology, 2019
Introduction: Allergic rhinitis is a chronic inflammatory disease which affects 1 out of 6 individuals. Perennial allergic rhinitis accounts for 40% of AR cases. Ciclesonide is one of the relatively new intranasal steroid for allergic rhinitis. Objective:
Qi Yang   +7 more
doaj   +3 more sources

Changes in nasal symptoms inflammatory cells over the course of perennial allergic rhinitis

open access: yesAllergology International, 1998
Nasal symptoms and inflammatory cells changes over the course of perennial allergic rhinitis have been analyzed only rarely. We studied nasal symptoms, nasal physical findings, and laboratory data in five groups, which consisted of varying time periods ...
Shinichi Kawabori   +4 more
doaj   +2 more sources

Nasal IgE in subjects with allergic and non-allergic rhinitis [PDF]

open access: yesWorld Allergy Organization Journal, 2020
Purpose: The prevalence of ''ocal allergic rhinitis'' within individuals suffering from perennial rhinitis remains uncertain, and patients usually are diagnosed with non-allergic rhinitis.
Jonas Eckrich   +6 more
doaj   +2 more sources

Mechanisms and Comparative Treatments of Allergic Rhinitis including Phototherapy

open access: yesAllergies
The treatment of allergic conditions presents a challenge for both seasonal allergic rhinitis and perennial rhinitis sufferers. The increasing prevalence of both of these types of allergic responses requires the use of a range of treatments which can ...
Roy Kennedy
doaj   +2 more sources

Intranasal ciclesonide for allergic rhinitis

open access: yesJournal of Asthma and Allergy, 2008
Ben Williams, William B Smith, Frank E KetteDepartment of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, South AustraliaAbstract: Ciclesonide is a novel corticosteroid which is optimized for topical use.
Ben Williams   +2 more
doaj   +1 more source

The effect of macrolides on allergic rhinitis versus chronic rhinosinusitis- an in-vitro study [PDF]

open access: yes, 2009
PhDBackground The mechanisms of the rhinitic process are complex. Previous studies upon nasal epithelial cells have begun to investigate rhinitis.
Kuchai, Romana
core   +4 more sources

Acupuncture in Seasonal Allergic Rhinitis (ACUSAR) - Design and Protocol of a Randomised Controlled Multi-Centre Trial [PDF]

open access: yes, 2010
Background: We report on the study design and protocol of a randomised controlled trial (Acupuncture in Seasonal Allergic Rhinitis, ACUSAR) that investigates the efficacy of acupuncture in the treatment of seasonal allergic rhinitis (SAR).
Witt, Claudia M.   +25 more
core   +1 more source

Perennial allergic rhinitis and keratoconjunctivitis [PDF]

open access: yesThorax, 2000
There are many studies dedicated to the allergic nose, but most of them deal with seasonal allergic rhinitis and particularly with acute experimental situations. Perennial allergic rhinitis is less well documented. When studying the allergic nose, several aspects must be taken into consideration: the genetic background of the patient, various ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy